To access publisher full text version of this article. Please click on the hyperlink in Additional Links fieldOBJECTIVES: To assess pregnant women's knowledge and understanding of first trimester prenatal screening (nuchal translucency, maternal serum free beta-human chorionic gonadotrophin and pregnancy-associated plasma-protein-A), to evaluate the impact of a new information booklet and investigate the effects of education and experiential knowledge of congenital disabilities on the perceived likelihood of accepting prenatal screening. DESIGN: A quasi-experimental quantitative study with a self-completion questionnaire. SETTING: Five different maternity care clinics in Iceland. POPULATION: Expectant mothers in first trimester of pregnancy...
Contains fulltext : 154468.pdf (publisher's version ) (Closed access)OBJECTIVE: Th...
Background and Goal: Screening of fetal anomalies is assumed as a necessary measurement in antenatal...
OBJECTIVE: To compare the experiences of women who received a screen-positive test result for Down s...
Introduction: First Trimester Screening (FTS) combines maternal age with fetal nuchal translucency (...
Background: Access to information about prenatal screening is important particularly in light of new...
Prenatal screening for fetal abnormalities is part of prenatal care in Finland. Participation is vol...
To access publisher's full text version of this article click on the hyperlink belowFirst-trimester ...
Problem: Fetal diagnoses are possible by the 16th week of gestation. Websites, social media, and mob...
Background: Prenatal maternal serum screening allows assessment of risk of chromosomal abnormalities...
Abstract: Introduction: The primary aim of this study is to investigate the impact of a 13-week anom...
Background: Proper knowledge about risk factors and prevention of congenital malformations in pregna...
Background Pregnant women should be under evaluation through screening tests during 11 - 1...
Background: Pregnant women should be under evaluation through screening tests during 11- 14 weeks of...
BackgroundAccess to information about prenatal screening is important particularly in light of new t...
INTRODUCTION: The primary aim of this study is to investigate the impact of a 13-week anomaly scan o...
Contains fulltext : 154468.pdf (publisher's version ) (Closed access)OBJECTIVE: Th...
Background and Goal: Screening of fetal anomalies is assumed as a necessary measurement in antenatal...
OBJECTIVE: To compare the experiences of women who received a screen-positive test result for Down s...
Introduction: First Trimester Screening (FTS) combines maternal age with fetal nuchal translucency (...
Background: Access to information about prenatal screening is important particularly in light of new...
Prenatal screening for fetal abnormalities is part of prenatal care in Finland. Participation is vol...
To access publisher's full text version of this article click on the hyperlink belowFirst-trimester ...
Problem: Fetal diagnoses are possible by the 16th week of gestation. Websites, social media, and mob...
Background: Prenatal maternal serum screening allows assessment of risk of chromosomal abnormalities...
Abstract: Introduction: The primary aim of this study is to investigate the impact of a 13-week anom...
Background: Proper knowledge about risk factors and prevention of congenital malformations in pregna...
Background Pregnant women should be under evaluation through screening tests during 11 - 1...
Background: Pregnant women should be under evaluation through screening tests during 11- 14 weeks of...
BackgroundAccess to information about prenatal screening is important particularly in light of new t...
INTRODUCTION: The primary aim of this study is to investigate the impact of a 13-week anomaly scan o...
Contains fulltext : 154468.pdf (publisher's version ) (Closed access)OBJECTIVE: Th...
Background and Goal: Screening of fetal anomalies is assumed as a necessary measurement in antenatal...
OBJECTIVE: To compare the experiences of women who received a screen-positive test result for Down s...